{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:00:26Z","timestamp":1772082026274,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.08.069","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T08:57:07Z","timestamp":1221814627000},"page":"6405-6414","source":"Crossref","is-referenced-by-count":47,"title":["Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene"],"prefix":"10.1016","volume":"26","author":[{"given":"Jonathan","family":"Cenna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy B.","family":"Papaneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Dietzschold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2008.08.069_bib1","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"Journal of Virology"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.069_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1086\/512243","article-title":"Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease","volume":"195","author":"McKenna","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.11.1.1","article-title":"Use of licensed vaccines for active immunization of the immunocompromised host","volume":"11","author":"Pirofski","year":"1998","journal-title":"Clinical Microbiology Reviews"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.069_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"Conzelmann","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.069_bib6","series-title":"Fields virology","first-page":"1137","article-title":"Rhabdoviruses","author":"Dietzschold","year":"1996"},{"key":"10.1016\/j.vaccine.2008.08.069_bib7","series-title":"Rhabdovirus genomes and their products","author":"Rose","year":"1987"},{"issue":"12","key":"10.1016\/j.vaccine.2008.08.069_bib8","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1128\/JVI.79.12.7673-7681.2005","article-title":"Identification of the rabies virus alpha\/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3","volume":"79","author":"Brzozka","year":"2005","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.virol.2003.10.001","article-title":"Generation and characterization of P gene-deficient rabies virus","volume":"318","author":"Shoji","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.069_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2005.03.011","article-title":"Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity","volume":"111","author":"Morimoto","year":"2005","journal-title":"Virus Research"},{"issue":"6386","key":"10.1016\/j.vaccine.2008.08.069_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/358507a0","article-title":"Evidence for a viral superantigen in humans","volume":"358","author":"Lafon","year":"1992","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.069_bib12","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/JVI.69.8.4957-4962.1995","article-title":"Cross-protection of mice against a global spectrum of rabies virus variants","volume":"69","author":"Lodmell","year":"1995","journal-title":"Journal of Virology"},{"issue":"22","key":"10.1016\/j.vaccine.2008.08.069_bib13","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0264-410X(00)00005-0","article-title":"Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines","volume":"18","author":"Lodmell","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.069_bib14","first-page":"650","article-title":"Recombinant replication-defective adenovirus based rabies vaccine","volume":"25","author":"Li","year":"2003","journal-title":"Chung Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae"},{"issue":"4","key":"10.1016\/j.vaccine.2008.08.069_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-1135(01)00523-5","article-title":"Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein","volume":"85","author":"Lees","year":"2002","journal-title":"Veterinary Microbiology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib16","first-page":"61","article-title":"Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain","volume":"15","author":"Li","year":"2001","journal-title":"Chinese Journal of Experimental & Clinical Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2008.08.069_bib17","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1099\/0022-1317-82-9-2191","article-title":"Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration","volume":"82","author":"Vos","year":"2001","journal-title":"Journal of General Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.069_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects nonhuman primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nature Medicine"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2008.08.069_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0264-410X(97)88325-9","article-title":"Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection","volume":"16","author":"Lodmell","year":"1998","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.08.069_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0264-410X(99)00352-7","article-title":"DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL)","volume":"18","author":"Lodmell","year":"2000","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2008.08.069_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","article-title":"One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination","volume":"20","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.069_bib22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(96)00281-2","article-title":"Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection","volume":"15","author":"Ray","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.069_bib23","first-page":"161","article-title":"Immunoprotection by rabies virus nucleoprotein","volume":"187","author":"Fu","year":"1994","journal-title":"Current Topics in Microbiology & Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.069_bib24","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1073\/pnas.88.5.2001","article-title":"Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine","volume":"88","author":"Fu","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.069_bib25","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1099\/vir.0.19116-0","article-title":"Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector","volume":"84","author":"Aspden","year":"1985","journal-title":"Journal of General Virology"},{"issue":"20","key":"10.1016\/j.vaccine.2008.08.069_bib26","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"Journal of Virology"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.069_bib27","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"Journal of Virology"},{"issue":"18","key":"10.1016\/j.vaccine.2008.08.069_bib28","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.069_bib30","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.050589197","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"Schnell","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","article-title":"Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G","volume":"73","author":"Mebatsion","year":"1999","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.069_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1574-6968.2001.tb10703.x","article-title":"Viral vectors as potential HIV-1 vaccines","volume":"200","author":"Schnell","year":"2001","journal-title":"FEMS Microbiology Letters"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.069_bib33","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1073\/pnas.95.6.3152","article-title":"Rabies virus quasispecies: implications for pathogenesis","volume":"95","author":"Morimoto","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.069_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.virol.2005.09.004","article-title":"Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2","volume":"344","author":"McGettigan","year":"2006","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.vaccine.2008.08.069_bib35","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1073\/pnas.0701397104","article-title":"The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription","volume":"104","author":"Tan","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2008.08.069_bib36","first-page":"47","article-title":"Antigenic activity and the reactogenicity of a concentrated, purified, UV-inactivated cultured rabies vaccine","volume":"9","author":"Dulina","year":"1983","journal-title":"Zhurnal Mikrobiologii, Epidemiologii, Iimmunobiologii"},{"issue":"10","key":"10.1016\/j.vaccine.2008.08.069_bib37","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1128\/JVI.71.10.7372-7380.1997","article-title":"Rabies virus infects mouse and human lymphocytes and induces apoptosis","volume":"71","author":"Thoulouze","year":"1997","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2008.08.069_bib38","unstructured":"WHO. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonic eggs. WHO Technical Report Series No. 941; 2007."},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.069_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/intimm\/12.2.223","article-title":"IFN-gamma-independent IgG2a production in mice infected with viruses and parasites","volume":"12","author":"Markine-Goriaynoff","year":"2000","journal-title":"International Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","article-title":"Oral vaccination of dogs with recombinant rabies virus vaccines","volume":"111","author":"Rupprecht","year":"2005","journal-title":"Virus Research"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.069_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/89289","article-title":"Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases","volume":"19","author":"Sasaki","year":"2001","journal-title":"Nature Biotechnology"},{"issue":"12","key":"10.1016\/j.vaccine.2008.08.069_bib42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.gt.3301696","article-title":"Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun","volume":"9","author":"Sasaki","year":"2002","journal-title":"Gene Therapy"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.069_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/89255","article-title":"Vaccines to die for","volume":"19","author":"Restifo","year":"2001","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib44","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/JVI.73.1.510-518.1999","article-title":"Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures","volume":"73","author":"Morimoto","year":"1999","journal-title":"Journal of Virology"},{"issue":"22","key":"10.1016\/j.vaccine.2008.08.069_bib45","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1128\/JVI.75.22.10800-10807.2001","article-title":"Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity","volume":"75","author":"Pulmanausahakul","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2008.08.069_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1196\/annals.1299.108","article-title":"Glycoprotein of nonpathogenic rabies viruses is a major inducer of apoptosis in human jurkat T cells","volume":"1010","author":"Lay","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.069_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0300-9084(03)00137-8","article-title":"Apoptosis and rabies virus neuroinvasion","volume":"85","author":"Baloul","year":"2003","journal-title":"Biochimie"},{"issue":"23","key":"10.1016\/j.vaccine.2008.08.069_bib48","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2005.06.027","article-title":"Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis","volume":"16","author":"Megret","year":"2005","journal-title":"Vaccine"},{"issue":"5 Suppl.","key":"10.1016\/j.vaccine.2008.08.069_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm0598supp-507","article-title":"Six decades of vaccine development\u2014a personal history","volume":"4","author":"Hilleman","year":"1998","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.069_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/72200","article-title":"Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?","volume":"6","author":"Burton","year":"2000","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"issue":"5753","key":"10.1016\/j.vaccine.2008.08.069_bib52","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.069_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri1266","article-title":"Human antibody-Fc receptor interactions illuminated by crystal structures","volume":"4","author":"Woof","year":"2004","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.069_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nature Reviews. Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T10:41:22Z","timestamp":1588934482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":54,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08011687"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}